カナダの双極性障害の治療ガイドライン。エビデンスに基づき(引用文献数が879!)分かりやすく作られているのでお勧めできるかも。 Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 20… https://t.co/maMFi3OTXM
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2018 – Feb 2025Where it's discussed
-
X / Twitter16 posts
-
News5 articles
-
Bluesky4 posts
-
YouTube4 videos
-
Facebook4 posts
-
Blogs3 articles
-
Reddit2 posts
AI synopsis
What people are saying
Discussions highlight the significance of the 2018 guidelines for bipolar disorder, with examples like the mention of the systematic review of cannabis use and the emphasis on treatment hierarchies, demonstrating an overall interest in clinical implications. The tone is professional and factual, reflecting respect for the guidelines’ role in shaping mental health management without strong disagreement or controversy.
Most discussions acknowledge the value and relevance of the guidelines, showing general support.
The posts indicate a moderate level of curiosity, especially regarding detailed content or specific applications.
Comments mostly involve sharing links or brief mentions, suggesting some engagement but limited deep discussion.
Several posts suggest that the guidelines influence ongoing research and clinical practices, indicating a noticeable but not transformative impact.
Abstract in brief
- The 2018 CANMAT and ISBD guidelines update previous bipolar disorder treatment recommendations by incorporating recent research and creating a clear hierarchy of first, second, and third-line treatments tailored for different illness phases like acute mania, depression, and maintenance.
- First-line treatments for acute mania in bipolar I disorder include medications such as lithium, quetiapine, divalproex, asenapine, aripiprazole, paliperidone, risperidone, and cariprazine, which can be used alone or combined.
- For bipolar I depression, top options are quetiapine, lurasidone plus lithium or divalproex, and standalone medications like lithium, lamotrigine, and lurasidone; continuing effective treatments through the maintenance phase is generally recommended, with some exceptions.]
Top posts
Most liked on X and BlueskyCanadian Network for Mood and Anxiety Treatments (#CANMAT) and International Society for #Bipolar Disorders (ISBD) recommendations for the management of patients with #bipolar disorder with #mixed presentations https://t.co/mQ48CIVD4Y
Interesting to note that the Canadian Network for Mood and Anxiety Treatments (CANMAT) simply define a trial with adequate sample size as ≥30 patients per randomized condition. journals.sagepub.com/doi/full/10....
Fonte: https://t.co/IHpYhIMYDd
The Canadian Journal of Psychiatry: The Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders. It's out, online & open access. #PerinatalMentalHealth #PMADs journals.sagepub.com/doi/10.1177/...
RT @Luke_629: Canadian Network for Mood and Anxiety Treatments (#CANMAT) and International Society for #Bipolar Disorders (ISBD) recommenda…
All mentions
2018 Bipolar Disorder Treatment Guidelines Overview
The 2018 CANMAT and ISBD guidelines update treatment recommendations for bipolar disorder, emphasizing first-line therapies for different phases like mania, depression, and maintenance, based on recent research…
Lamotrigine Overview for Bipolar Disorder Treatment and Management
This video discusses lamotrigine Lamictal, an anticonvulsant used to treat bipolar depression and maintenance, covering its uses, onset of action, side effects, drug interactions, and final insights.
Antidepressants in Bipolar Disorder Treatment and Safety
This video discusses the use of antidepressants in bipolar disorder, referencing recent guidelines and research. It covers medication efficacy, safety, and treatment strategies during various illness phases, emphasizing…
Sublingual Asenapine for Agitation in Malabsorptive Conditions: Case Review
Gastric malabsorptive conditions can prevent patients from benefiting from oral medications. Sublingual asenapine is a viable option as it bypasses gut absorption. Three patients with different conditions showed…
The Canadian Journal of Psychiatry: The Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders. It's out, online & open access. #PerinatalMentalHealth #PMADs journals.sagepub.com/doi/10.1177/...
Interesting to note that the Canadian Network for Mood and Anxiety Treatments (CANMAT) simply define a trial with adequate sample size as ≥30 patients per randomized condition. journals.sagepub.com/doi/full/10....
@igoreckert Claro, tem em outras guidelines também como possível agente coadjuvante, nao tenho em maos agora. https://t.co/XrZo56HHYn
may_2023 - Systematic Review: Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder...
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 20… https://t.co/TvOZ5kjNjH
RT @Luke_629: Canadian Network for Mood and Anxiety Treatments (#CANMAT) and International Society for #Bipolar Disorders (ISBD) recommenda…
Fonte: https://t.co/IHpYhIMYDd
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) re… https://t.co/hPKvQBIU9f
RT @Luke_629: Canadian Network for Mood and Anxiety Treatments (#CANMAT) and International Society for #Bipolar Disorders (ISBD) recommenda…
RT @Luke_629: Canadian Network for Mood and Anxiety Treatments (#CANMAT) and International Society for #Bipolar Disorders (ISBD) recommenda…
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations #mentalhealth https://t.co/gO63gJT6vZ
RT @Luke_629: Canadian Network for Mood and Anxiety Treatments (#CANMAT) and International Society for #Bipolar Disorders (ISBD) recommenda…
Canadian Network for Mood and Anxiety Treatments (#CANMAT) and International Society for #Bipolar Disorders (ISBD) recommendations for the management of patients with #bipolar disorder with #mixed presentations https://t.co/mQ48CIVD4Y
RT @89089314: カナダの双極性障害の治療ガイドライン。エビデンスに基づき(引用文献数が879!)分かりやすく作られているのでお勧めできるかも。 Canadian Network for Mood and Anxiety Treatments (CANMAT) and…
RT @89089314: カナダの双極性障害の治療ガイドライン。エビデンスに基づき(引用文献数が879!)分かりやすく作られているのでお勧めできるかも。 Canadian Network for Mood and Anxiety Treatments (CANMAT) and…
RT @89089314: カナダの双極性障害の治療ガイドライン。エビデンスに基づき(引用文献数が879!)分かりやすく作られているのでお勧めできるかも。 Canadian Network for Mood and Anxiety Treatments (CANMAT) and…
RT @89089314: カナダの双極性障害の治療ガイドライン。エビデンスに基づき(引用文献数が879!)分かりやすく作られているのでお勧めできるかも。 Canadian Network for Mood and Anxiety Treatments (CANMAT) and…
RT @89089314: カナダの双極性障害の治療ガイドライン。エビデンスに基づき(引用文献数が879!)分かりやすく作られているのでお勧めできるかも。 Canadian Network for Mood and Anxiety Treatments (CANMAT) and…
カナダの双極性障害の治療ガイドライン。エビデンスに基づき(引用文献数が879!)分かりやすく作られているのでお勧めできるかも。 Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 20… https://t.co/maMFi3OTXM
Our studies contribute to the new Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines @MarstonLouise @DrAPitman @osborn_ucl @UCLPsychiatry